-
2
-
-
33845489470
-
High prevalence of pituitary adenomas: A cross-sectional study in the province of liege, belgium
-
Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: A cross-sectional study in the province of liege, belgium. J Clin Endocrinol Metab 2006;91:4769-75
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4769-4775
-
-
Daly, A.F.1
Rixhon, M.2
Adam, C.3
-
3
-
-
80053927915
-
Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population
-
Rosario PW. Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population. Pituitary 2011;14:217-21
-
(2011)
Pituitary
, vol.14
, pp. 217-221
-
-
Rosario, P.W.1
-
5
-
-
0023886723
-
Epidemiology and long-term survival in acromegaly A study of 166 cases diagnosed between 1955 and 1984
-
Bengtsson BA, Eden S, Ernest I, et al. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327-35
-
(1988)
Acta Med Scand
, vol.223
, pp. 327-335
-
-
Bengtsson, B.A.1
Eden, S.2
Ernest, I.3
-
6
-
-
0031774361
-
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly
-
Swearingen B, Barker FG II, Katznelson L, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-26
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3419-3426
-
-
Swearingen, B.1
Barker, I.I.F.G.2
Katznelson, L.3
-
7
-
-
49649124901
-
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
-
Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 2008;159:89-95
-
(2008)
Eur J Endocrinol
, vol.159
, pp. 89-95
-
-
Holdaway, I.M.1
Bolland, M.J.2
Gamble, G.D.3
-
8
-
-
84948721761
-
Histochemical characterization of the cutaneous involvement of acromegaly
-
Matsuoka LY, Wortsman J, Kupchella CE, et al. Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med 1982;142:1820-3
-
(1982)
Arch Intern Med
, vol.142
, pp. 1820-1823
-
-
Matsuoka, L.Y.1
Wortsman, J.2
Kupchella, C.E.3
-
9
-
-
0020310068
-
The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours
-
Jadresic A, Banks LM, Child DF, et al. The acromegaly syndrome. relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med 1982;51:189-204
-
(1982)
Q J Med
, vol.51
, pp. 189-204
-
-
Jadresic, A.1
Banks, L.M.2
Child, D.F.3
-
10
-
-
79960108314
-
A novel approach to the detection of acromegaly: Accuracy of diagnosis by automatic face classification
-
Schneider HJ, Kosilek RP, Gunther M, et al. A novel approach to the detection of acromegaly: Accuracy of diagnosis by automatic face classification. J Clin Endocrinol Metab 2011;96:2074-80
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 2074-2080
-
-
Schneider, H.J.1
Kosilek, R.P.2
Gunther, M.3
-
12
-
-
76149126990
-
Endocrine aspects of obstructive sleep apnea
-
Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 2010;95:483-95
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 483-495
-
-
Attal, P.1
Chanson, P.2
-
13
-
-
84874860258
-
A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy
-
Annamalai AK, Webb A, Kandasamy N, et al. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 2013;98:1040-50
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 1040-1050
-
-
Annamalai, A.K.1
Webb, A.2
Kandasamy, N.3
-
14
-
-
18844370346
-
Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life
-
Biermasz NR, Pereira AM, Smit JW, et al. Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 2005;90:2731-9
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 2731-2739
-
-
Biermasz, N.R.1
Pereira, A.M.2
Smit, J.W.3
-
15
-
-
0034254774
-
The pathology of median neuropathy in acromegaly
-
Jenkins PJ, Sohaib SA, Akker S, et al. The pathology of median neuropathy in acromegaly. Ann Intern Med 2000;133:197-201
-
(2000)
Ann Intern Med
, vol.133
, pp. 197-201
-
-
Jenkins, P.J.1
Sohaib, S.A.2
Akker, S.3
-
16
-
-
26644464576
-
Hypertension in acromegaly and in the normal population: Prevalence and determinants
-
Vitale G, Pivonello R, Auriemma RS, et al. Hypertension in acromegaly and in the normal population: Prevalence and determinants. Clin Endocrinol (Oxf ) 2005;63:470-6
-
(2005)
Clin Endocrinol (Oxf
, vol.63
, pp. 470-476
-
-
Vitale, G.1
Pivonello, R.2
Auriemma, R.S.3
-
17
-
-
1542269637
-
Prevalence and determinants of left ventricular hypertrophy in acromegaly: Impact of different methods of indexing left ventricular mass
-
Vitale G, Galderisi M, Pivonello R, et al. Prevalence and determinants of left ventricular hypertrophy in acromegaly: Impact of different methods of indexing left ventricular mass. Clin Endocrinol( Oxf ) 2004;60:343-9
-
(2004)
Clin Endocrinol( Oxf
, vol.60
, pp. 343-349
-
-
Vitale, G.1
Galderisi, M.2
Pivonello, R.3
-
18
-
-
80054802844
-
Determinants of cardiac disease in newly diagnosed patients with acromegaly: Results of a 10 year survey study
-
Colao A, Pivonello R, Grasso LF, et al. Determinants of cardiac disease in newly diagnosed patients with acromegaly: Results of a 10 year survey study. Eur J Endocrinol 2011;165:713-21
-
(2011)
Eur J Endocrinol
, vol.165
, pp. 713-721
-
-
Colao, A.1
Pivonello, R.2
Grasso, L.F.3
-
19
-
-
8744228134
-
Long-term outcome of patients with acromegaly and congestive heart failure
-
Bihan H, Espinosa C, Valdes-Socin H, et al. Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 2004;89:5308-13
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5308-5313
-
-
Bihan, H.1
Espinosa, C.2
Valdes-Socin, H.3
-
20
-
-
39149139330
-
Acromegaly: Re-thinking the cancer risk
-
Loeper S, Ezzat S. Acromegaly: Re-thinking the cancer risk. Rev Endocr Metab Disord 2008;9:41-58
-
(2008)
Rev Endocr Metab Disord
, vol.9
, pp. 41-58
-
-
Loeper, S.1
Ezzat, S.2
-
21
-
-
33845491265
-
Medical progress: Acromegaly
-
Melmed S. Medical progress: Acromegaly. N Engl J Med 2006;355:2558-73
-
(2006)
N Engl J Med
, vol.355
, pp. 2558-2573
-
-
Melmed, S.1
-
22
-
-
49249115728
-
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
-
Rokkas T, Pistiolas D, Sechopoulos P, et al. Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis. World J Gastroenterol 2008;14:3484-9
-
(2008)
World J Gastroenterol
, vol.14
, pp. 3484-3489
-
-
Rokkas, T.1
Pistiolas, D.2
Sechopoulos, P.3
-
23
-
-
0036802441
-
British society for gastroenterology association of coloproctology for great britain and ireland screening guidelines for colorectal cancer and polyps in patients with acromegaly
-
Jenkins PJ, Fairclough PD; British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut 2002;51:V13-14
-
(2002)
Gut
, vol.51
-
-
Jenkins, P.J.1
Fairclough, P.D.2
-
24
-
-
84873742122
-
Thyroid cancer in patients with acromegaly: A case-control study
-
dos Santos MC, Nascimento GC, Nascimento AG, et al. Thyroid cancer in patients with acromegaly: A case-control study. Pituitary 2013;16:109-14
-
(2013)
Pituitary
, vol.16
, pp. 109-114
-
-
Dos Santos, M.C.1
Nascimento, G.C.2
Nascimento, A.G.3
-
25
-
-
77955895409
-
Thyroid cancer is the most common cancer associated with acromegaly
-
Gullu BE, Celik O, Gazioglu N, et al. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 2010;13:242-8
-
(2010)
Pituitary
, vol.13
, pp. 242-248
-
-
Gullu, B.E.1
Celik, O.2
Gazioglu, N.3
-
27
-
-
0036462174
-
Oncological complications of excess GH in acromegaly
-
Webb SM, Casanueva F, Wass JA. Oncological complications of excess GH in acromegaly. Pituitary 2002;5:21-5
-
(2002)
Pituitary
, vol.5
, pp. 21-25
-
-
Webb, S.M.1
Casanueva, F.2
Wass, J.A.3
-
28
-
-
77954845856
-
Mortality in patients with pituitary disease
-
Sherlock M, Ayuk J, Tomlinson JW, et al. Mortality in patients with pituitary disease. Endocr Rev 2010;31:301-42
-
(2010)
Endocr Rev
, vol.31
, pp. 301-342
-
-
Sherlock, M.1
Ayuk, J.2
Tomlinson, J.W.3
-
29
-
-
7244257406
-
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the spanish acromegaly registry (registro espanol de acromegalia, REA
-
Mestron A, Webb SM, Astorga R, et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the spanish acromegaly registry (registro espanol de acromegalia, REA). Eur J Endocrinol 2004;151:439-46
-
(2004)
Eur J Endocrinol
, vol.151
, pp. 439-446
-
-
Mestron, A.1
Webb, S.M.2
Astorga, R.3
-
30
-
-
0034037529
-
Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
-
Kasayama S, Otsuki M, Takagi M, et al. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol( Oxf ) 2000;52:549-55
-
(2000)
Clin Endocrinol( Oxf
, vol.52
, pp. 549-555
-
-
Kasayama, S.1
Otsuki, M.2
Takagi, M.3
-
31
-
-
79957784185
-
Diabetes in acromegaly, prevalence, risk factors, and evolution: Data from the french acromegaly registry
-
Fieffe S, Morange I, Petrossians P, et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: Data from the french acromegaly registry. Eur J Endocrinol 2011;164:877-84
-
(2011)
Eur J Endocrinol
, vol.164
, pp. 877-884
-
-
Fieffe, S.1
Morange, I.2
Petrossians, P.3
-
34
-
-
84871951676
-
Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature
-
Shah R, Licata A, Oyesiku NM, et al. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature. Pituitary 2012;15:S17-22
-
(2012)
Pituitary
, vol.15
-
-
Shah, R.1
Licata, A.2
Oyesiku, N.M.3
-
35
-
-
33644822471
-
Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity
-
White HD, Ahmad AM, Durham BH, et al. Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity. J Clin Endocrinol Metab 2006;91:913-19
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 913-919
-
-
White, H.D.1
Ahmad, A.M.2
Durham, B.H.3
-
36
-
-
18644379128
-
Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: Distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia
-
Ueda M, Inaba M, Tahara H, et al. Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: Distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia. Intern Med 2005;44:307-10
-
(2005)
Intern Med
, vol.44
, pp. 307-310
-
-
Ueda, M.1
Inaba, M.2
Tahara, H.3
-
37
-
-
0025816183
-
The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy
-
Matucci-Cerinic M, Lotti T, Jajic I, et al. The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine (Baltimore) 1991;70:208-14
-
(1991)
Medicine (Baltimore
, vol.70
, pp. 208-214
-
-
Matucci-Cerinic, M.1
Lotti, T.2
Jajic, I.3
-
38
-
-
84877107417
-
Primary hypothyroidism presenting as pseudoacromegaly
-
Kumar KV, Shaikh A, Anwar I, et al. Primary hypothyroidism presenting as pseudoacromegaly. Pituitary 2012;15:S49-52
-
(2012)
Pituitary
, vol.15
-
-
Kumar, K.V.1
Shaikh, A.2
Anwar, I.3
-
39
-
-
84883163449
-
Acromegaloid facial appearance: Case report and literature review
-
Ghazi A, Khosla S, Becker K. Acromegaloid facial appearance: Case report and literature review. Case Rep Endocrinol 2013;2013:970396
-
(2013)
Case Rep Endocrinol
, vol.2013
, pp. 970396
-
-
Ghazi, A.1
Khosla, S.2
Becker, K.3
-
40
-
-
10244245501
-
Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly
-
Kumar S, Durrington PN, ORahilly S, et al. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab 1996;81:3465-8
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 3465-3468
-
-
Kumar, S.1
Durrington, P.N.2
Orahilly, S.3
-
42
-
-
84856282107
-
American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update: Executive summary
-
Katznelson L, Atkinson JL, Cook DM, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update: Executive summary. Endocr Pract 2011;17:636-46
-
(2011)
Endocr Pract
, vol.17
, pp. 636-646
-
-
Katznelson, L.1
Atkinson, J.L.2
Cook, D.M.3
-
43
-
-
84871366665
-
Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone
-
Subbarayan SK, Fleseriu M, Gordon MB, et al. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocr Pract 2012;18:817-25
-
(2012)
Endocr Pract
, vol.18
, pp. 817-825
-
-
Subbarayan, S.K.1
Fleseriu, M.2
Gordon, M.B.3
-
44
-
-
10744225758
-
Serum insulin-like growth factor i reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study
-
Brabant G, von zur Muhlen A, Wuster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study. Horm Res 2003;60:53-60
-
(2003)
Horm Res
, vol.60
, pp. 53-60
-
-
Brabant, G.1
Von Zur Muhlen, A.2
Wuster, C.3
-
45
-
-
14044272879
-
Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity
-
Gleeson HK, Lissett CA, Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab 2005;90:1061-7
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1061-1067
-
-
Gleeson, H.K.1
Lissett, C.A.2
Shalet, S.M.3
-
47
-
-
33744523193
-
Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects
-
Schneider HJ, Saller B, Klotsche J, et al. Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 2006;15:699-706
-
(2006)
Eur J Endocrinol
, vol.15
, pp. 699-706
-
-
Schneider, H.J.1
Saller, B.2
Klotsche, J.3
-
48
-
-
61849158161
-
Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults
-
Berrigan D, Potischman N, Dodd KW, et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 2009;19:146-55
-
(2009)
Growth Horm IGF Res
, vol.19
, pp. 146-155
-
-
Berrigan, D.1
Potischman, N.2
Dodd, K.W.3
-
49
-
-
84861982113
-
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes
-
vii-viii
-
Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 2012;41:425-43. vii-viii
-
(2012)
Endocrinol Metab Clin North Am
, vol.41
, pp. 425-443
-
-
Clemmons, D.R.1
-
51
-
-
34249869743
-
Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice
-
Pokrajac A, Wark G, Ellis AR, et al. Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice. Clin Endocrinol (Oxf ) 2007;67:65-70
-
(2007)
Clin Endocrinol (Oxf
, vol.67
, pp. 65-70
-
-
Pokrajac, A.1
Wark, G.2
Ellis, A.R.3
-
52
-
-
0037502831
-
A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum
-
Chen JW, Ledet T, Orskov H, et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 2003;284:E1149-55
-
(2003)
Am J Physiol Endocrinol Metab
, vol.284
-
-
Chen, J.W.1
Ledet, T.2
Orskov, H.3
-
53
-
-
47549110969
-
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays
-
Brugts MP, Ranke MB, Hofland LJ, et al. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays. J Clin Endocrinol Metab 2008;93:2539-45
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 2539-2545
-
-
Brugts, M.P.1
Ranke, M.B.2
Hofland, L.J.3
-
54
-
-
84875139918
-
Soluble alpha-klotho: A novel serum biomarker for the activity of GH-producing pituitary adenomas
-
Neidert MC, Sze L, Zwimpfer C, et al. Soluble alpha-klotho: A novel serum biomarker for the activity of GH-producing pituitary adenomas. Eur J Endocrinol 2013;168:575-83
-
(2013)
Eur J Endocrinol
, vol.168
, pp. 575-583
-
-
Neidert, M.C.1
Sze, L.2
Zwimpfer, C.3
-
55
-
-
84862646695
-
Excessively high soluble klotho in patients with acromegaly
-
Sze L, Bernays RL, Zwimpfer C, et al. Excessively high soluble klotho in patients with acromegaly. J Intern Med 2012;272:93-7
-
(2012)
J Intern Med
, vol.272
, pp. 93-97
-
-
Sze, L.1
Bernays, R.L.2
Zwimpfer, C.3
-
56
-
-
0033818901
-
Clinical and reimbursement issues in growth hormone use in adults
-
Biller BM, Vance ML, Kleinberg DL, et al. Clinical and reimbursement issues in growth hormone use in adults. Am J Manag Care 2000;6:S817-27
-
(2000)
Am J Manag Care
, vol.6
-
-
Biller, B.M.1
Vance, M.L.2
Kleinberg, D.L.3
-
57
-
-
0023684610
-
Plasma insulin-like growth factor-I/ somatomedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion
-
Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor-I/ somatomedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 1988;67:69-73
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 69-73
-
-
Barkan, A.L.1
Beitins, I.Z.2
Kelch, R.P.3
-
58
-
-
18844375867
-
Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein( IGFBP)-1 to IGFBP-4: Implications for cardiovascular risk
-
Heald A, Kaushal K, Anderson S, et al. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein( IGFBP)-1 to IGFBP-4: Implications for cardiovascular risk. Gynecol Endocrinol 2005;20:176-82
-
(2005)
Gynecol Endocrinol
, vol.20
, pp. 176-182
-
-
Heald, A.1
Kaushal, K.2
Anderson, S.3
-
59
-
-
42049103897
-
Growth hormone response during oral glucose tolerance test: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index
-
Arafat AM, Mohlig M, Weickert MO, et al. Growth hormone response during oral glucose tolerance test: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 2008;93:1254-62
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 1254-1262
-
-
Arafat, A.M.1
Mohlig, M.2
Weickert, M.O.3
-
60
-
-
84861971962
-
Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men
-
Iranmanesh A, Lawson D, Veldhuis JD. Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men. J Clin Endocrinol Metab 2012;97:2172-9
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2172-2179
-
-
Iranmanesh, A.1
Lawson, D.2
Veldhuis, J.D.3
-
61
-
-
84861455879
-
Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience
-
Minuto FM, Resmini E, Boschetti M, et al. Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience. Pituitary 2012;15:215-21
-
(2012)
Pituitary
, vol.15
, pp. 215-221
-
-
Minuto, F.M.1
Resmini, E.2
Boschetti, M.3
-
62
-
-
0030746256
-
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion
-
Grottoli S, Procopio M, Maccario M, et al. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. J Clin Endocrinol Metab 1997;82:2261-5
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 2261-2265
-
-
Grottoli, S.1
Procopio, M.2
MacCario, M.3
-
63
-
-
0028270653
-
Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women
-
Chapman IM, Hartman ML, Straume M, et al. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994;78:1312-19
-
(1994)
J Clin Endocrinol Metab
, vol.78
, pp. 1312-1319
-
-
Chapman, I.M.1
Hartman, M.L.2
Straume, M.3
-
64
-
-
0036345609
-
Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up
-
Dimaraki EV, Jaffe CA, DeMott-Friberg R, et al. Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up. J Clin Endocrinol Metab 2002;87:3537-42
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3537-3542
-
-
Dimaraki, E.V.1
Jaffe, C.A.2
Demott-Friberg, R.3
-
65
-
-
78751493190
-
Limited utility of oral glucose tolerance test in biochemically active acromegaly
-
had 0.4 mg/l and limited role of OGTT in patients with low GH secretion
-
Ribeiro-Oliveira A Jr, Faje AT, Barkan AL. Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol 2011;164:17-22 had
-
(2011)
Eur J Endocrinol
, vol.164
, pp. 17-22
-
-
Ribeiro-Oliveira Jr., A.1
Faje, A.T.2
Barkan, A.L.3
-
66
-
-
0037318236
-
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly
-
Grottoli S, Razzore P, Gaia D, et al. Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. J Endocrinol Invest 2003;26:123-7
-
(2003)
J Endocrinol Invest
, vol.26
, pp. 123-127
-
-
Grottoli, S.1
Razzore, P.2
Gaia, D.3
-
67
-
-
0031763448
-
Evaluation of disease status with sensitive measures of growth hormone secretion in postoperative patients with acromegaly
-
Freda PU, Post KD, Powell JS, et al. Evaluation of disease status with sensitive measures of growth hormone secretion in postoperative patients with acromegaly. J Clin Endocrinol Metab 1998;83:3808-16
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3808-3816
-
-
Freda, P.U.1
Post, K.D.2
Powell, J.S.3
-
68
-
-
0023727258
-
Growth factors and the thyroid: Effects of treatment for hyper- and hypothyroidism on serum IGF-I and urinary epidermal growth factor concentrations
-
Westermark K, Alm J, Skottner A, et al. Growth factors and the thyroid: Effects of treatment for hyper- and hypothyroidism on serum IGF-I and urinary epidermal growth factor concentrations. Acta Endocrinol (Copenh) 1988;118:415-21
-
(1988)
Acta Endocrinol (Copenh
, vol.118
, pp. 415-421
-
-
Westermark, K.1
Alm, J.2
Skottner, A.3
-
69
-
-
34249886308
-
IGF-I assays: Current assay methodologies and their limitations
-
Clemmons DR. IGF-I assays: Current assay methodologies and their limitations. Pituitary 2007;10:121-8
-
(2007)
Pituitary
, vol.10
, pp. 121-128
-
-
Clemmons, D.R.1
-
70
-
-
79956157928
-
Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays
-
Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 2011;57:555-9
-
(2011)
Clin Chem
, vol.57
, pp. 555-559
-
-
Clemmons, D.R.1
-
71
-
-
59749084581
-
The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly
-
Carmichael JD, Bonert VS, Mirocha JM, et al. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 2009;94:523-7
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 523-527
-
-
Carmichael, J.D.1
Bonert, V.S.2
Mirocha, J.M.3
-
72
-
-
46949108045
-
Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR
-
Machado EO, Taboada GF, Neto LV, et al. Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. Growth Horm IGF Res 2008;18:389-93
-
(2008)
Growth Horm IGF Res
, vol.18
, pp. 389-393
-
-
MacHado, E.O.1
Taboada, G.F.2
Neto, L.V.3
-
73
-
-
84870320908
-
Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naive to medical therapy and radiation: What to follow, GH or IGF-1 values?
-
Brzana JA, Yedinak CG, Delashaw JB, et al. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naive to medical therapy and radiation: What to follow, GH or IGF-1 values? Pituitary 2012;15:562-70
-
(2012)
Pituitary
, vol.15
, pp. 562-570
-
-
Brzana, J.A.1
Yedinak, C.G.2
Delashaw, J.B.3
-
74
-
-
0027483351
-
Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins
-
Miell JP, Taylor AM, Zini M, et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 1993;76:950-5
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 950-955
-
-
Miell, J.P.1
Taylor, A.M.2
Zini, M.3
-
75
-
-
66749136426
-
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly
-
Bianchi A, Giustina A, Cimino V, et al. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 2009;94:2015-22
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 2015-2022
-
-
Bianchi, A.1
Giustina, A.2
Cimino, V.3
-
76
-
-
33644525358
-
Serum IGF-1 in treated acromegaly - How normal is normal?
-
Lansang C, Chitaia N, Simpson NE, et al. Serum IGF-1 in treated acromegaly - how normal is normal? Pituitary 2005;8:135-8
-
(2005)
Pituitary
, vol.8
, pp. 135-138
-
-
Lansang, C.1
Chitaia, N.2
Simpson, N.E.3
-
78
-
-
0035944825
-
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
-
Van Der Lely AJ, Hutson RK, Trainer PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 2001;358:1754-9
-
(2001)
Lancet
, vol.358
, pp. 1754-1759
-
-
Van Der Lely, A.J.1
Hutson, R.K.2
Trainer, P.J.3
-
79
-
-
76149125135
-
Growth hormone deficiency after treatment of acromegaly: A randomized, placebo-controlled study of growth hormone replacement
-
Miller KK, Wexler T, Fazeli P, et al. Growth hormone deficiency after treatment of acromegaly: A randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab 2010;95:567-77
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 567-577
-
-
Miller, K.K.1
Wexler, T.2
Fazeli, P.3
-
81
-
-
80054755358
-
Initial experience of 3 tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours
-
Stobo DB, Lindsay RS, Connell JM, et al. Initial experience of 3 tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours. Clin Endocrinol( Oxf ) 2011;75:673-7
-
(2011)
Clin Endocrinol( Oxf
, vol.75
, pp. 673-677
-
-
Stobo, D.B.1
Lindsay, R.S.2
Connell, J.M.3
-
82
-
-
84877122364
-
Acromegaly due to an ectopic pituitary adenoma in the clivus: Case report and review of literature
-
Appel JG, Bergsneider M, Vinters H, et al. Acromegaly due to an ectopic pituitary adenoma in the clivus: Case report and review of literature. Pituitary 2012;15:S53-6
-
(2012)
Pituitary
, vol.15
-
-
Appel, J.G.1
Bergsneider, M.2
Vinters, H.3
-
83
-
-
84862018622
-
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
-
Heck A, Ringstad G, Fougner SL, et al. Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf ) 2012;77:72-8
-
(2012)
Clin Endocrinol (Oxf
, vol.77
, pp. 72-78
-
-
Heck, A.1
Ringstad, G.2
Fougner, S.L.3
-
84
-
-
79955664599
-
Increased rate of intracranial saccular aneurysms in acromegaly: An MR angiography study and review of the literature
-
Manara R, Maffei P, Citton V, et al. Increased rate of intracranial saccular aneurysms in acromegaly: An MR angiography study and review of the literature. J Clin Endocrinol Metab 2011;96:1292-300
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 1292-300
-
-
Manara, R.1
Maffei, P.2
Citton, V.3
-
85
-
-
84878752414
-
Prevalence of cerebral aneurysm in patients with acromegaly
-
Oshino S, Nishino A, Suzuki T, et al. Prevalence of cerebral aneurysm in patients with acromegaly. Pituitary 2012;16:195-201
-
(2012)
Pituitary
, vol.16
, pp. 195-201
-
-
Oshino, S.1
Nishino, A.2
Suzuki, T.3
-
87
-
-
84888199902
-
Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: A large single center experience
-
Epub ahead of print
-
Brzana J, Yedinak CG, Gultekin SH, et al. Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: A large single center experience. Pituitary 2012. [Epub ahead of print
-
(2012)
Pituitary
-
-
Brzana, J.1
Yedinak, C.G.2
Gultekin, S.H.3
-
88
-
-
84875156034
-
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
-
Larkin S, Reddy R, Karavitaki N, et al. Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. Eur J Endocrinol 2013;168:491-9
-
(2013)
Eur J Endocrinol
, vol.168
, pp. 491-499
-
-
Larkin, S.1
Reddy, R.2
Karavitaki, N.3
-
89
-
-
84872070630
-
Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly
-
Gatto F, Feelders RA, Van Der Pas R, et al. Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2013;98:E66-71
-
(2013)
J Clin Endocrinol Metab
, vol.98
-
-
Gatto, F.1
Feelders, R.A.2
Van Der Pas, R.3
-
90
-
-
84898833299
-
Absence of immunostaining for growth hormone in a subset of patients with acromegaly
-
Epub ahead of print
-
Schroeder JL, Spiotta AM, Fleseriu M, et al. Absence of immunostaining for growth hormone in a subset of patients with acromegaly. Pituitary 2013; Epub ahead of print
-
(2013)
Pituitary
-
-
Schroeder, J.L.1
Spiotta, A.M.2
Fleseriu, M.3
-
91
-
-
77956574952
-
Approach to the patient with persistent acromegaly after pituitary surgery
-
Katznelson L. Approach to the patient with persistent acromegaly after pituitary surgery. J Clin Endocrinol Metab 2010;95:4114-23
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 4114-4123
-
-
Katznelson, L.1
-
92
-
-
79958135906
-
Efficacy and complications of neurosurgical treatment of acromegaly
-
Krzentowska-Korek A, Golkowski F, Baldys-Waligorska A, et al. Efficacy and complications of neurosurgical treatment of acromegaly. Pituitary 2011;14:157-62
-
(2011)
Pituitary
, vol.14
, pp. 157-162
-
-
Krzentowska-Korek, A.1
Golkowski, F.2
Baldys-Waligorska, A.3
-
93
-
-
84862114485
-
The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: Clinical analysis of 279 cases
-
Wang M, Mou C, Jiang M, et al. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: Clinical analysis of 279 cases. Eur J Endocrinol 2012;166:797-802
-
(2012)
Eur J Endocrinol
, vol.166
, pp. 797-802
-
-
Wang, M.1
Mou, C.2
Jiang, M.3
-
94
-
-
0021809469
-
Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy
-
Takamoto S, Tsuchiya H, Onishi T, et al. Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J Clin Endocrinol Metab 1985;61:7-11
-
(1985)
J Clin Endocrinol Metab
, vol.61
, pp. 7-11
-
-
Takamoto, S.1
Tsuchiya, H.2
Onishi, T.3
-
95
-
-
84858160589
-
Pregnancy and acromegaly: A review
-
Cheng V, Faiman C, Kennedy L, et al. Pregnancy and acromegaly: A review. Pituitary 2012;15:59-63
-
(2012)
Pituitary
, vol.15
, pp. 59-63
-
-
Cheng, V.1
Faiman, C.2
Kennedy, L.3
-
96
-
-
84863888447
-
Familial gigantism
-
Herder WW. Familial gigantism. Clinics (Sao Paulo) 2012;67:29-32
-
(2012)
Clinics (Sao Paulo
, vol.67
, pp. 29-32
-
-
Herder, W.W.1
-
97
-
-
2442473829
-
Activating gsalpha mutations: Analysis of 113 patients with signs of McCune-albright syndrome-a european collaborative study
-
European Collaborative Study
-
Lumbroso S, Paris F, Sultan C. European Collaborative Study. Activating gsalpha mutations: Analysis of 113 patients with signs of McCune-albright syndrome-a european collaborative study. J Clin Endocrinol Metab 2004;89:2107-13
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2107-2113
-
-
Lumbroso, S.1
Paris, F.2
Sultan, C.3
-
98
-
-
84863569161
-
Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-albright syndrome
-
Vortmeyer AO, Glasker S, Mehta GU, et al. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-albright syndrome. J Clin Endocrinol Metab 2012;97:2404-13
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2404-2413
-
-
Vortmeyer, A.O.1
Glasker, S.2
Mehta, G.U.3
-
99
-
-
18244392974
-
Pituitary disease in MEN type 1( MEN1): Data from the france-belgium MEN1 multicenter study
-
Verges B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1( MEN1): Data from the france-belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;87:457-65
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 457-465
-
-
Verges, B.1
Boureille, F.2
Goudet, P.3
-
100
-
-
0033767048
-
Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (carney complex
-
Pack SD, Kirschner LS, Pak E, et al. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (carney complex). J Clin Endocrinol Metab 2000;85:3860-5
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 3860-3865
-
-
Pack, S.D.1
Kirschner, L.S.2
Pak, E.3
-
101
-
-
79951999077
-
Familial isolated pituitary adenomas experience at a single center: Clinical importance of AIP mutation screening
-
Pinho LK, Vieira Neto L, Wildemberg LE, et al. Familial isolated pituitary adenomas experience at a single center: Clinical importance of AIP mutation screening. Arq Bras Endocrinol Metabol 2010;54:698-704
-
(2010)
Arq Bras Endocrinol Metabol
, vol.54
, pp. 698-704
-
-
Pinho, L.K.1
Vieira Neto, L.2
Wildemberg, L.E.3
-
102
-
-
77954316421
-
Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA
-
Chahal HS, Chapple JP, Frohman LA, et al. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 2010;21:419-27
-
(2010)
Trends Endocrinol Metab
, vol.21
, pp. 419-427
-
-
Chahal, H.S.1
Chapple, J.P.2
Frohman, L.A.3
-
103
-
-
84883194585
-
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone( GHRH): A french nationwide series of 21 cases
-
Garby L, Caron P, Claustrat F, et al. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone( GHRH): A french nationwide series of 21 cases. J Clin Endo
-
J Clin Endo
-
-
Garby, L.1
Caron, P.2
Claustrat, F.3
|